Deficits or pathogenic mutations in BEACH-containing proteins other than WDFY3 in humans (Fig. 2B) are associated with bipolar disorder, schizophrenia, epilepsy, ASD, and neurodegenerative diseases, such as AD, ALS and Parkinson’s disease (Fig. 2B). This evidence concerns the gene WDFY3 and Alzheimer disease.